Inhibition of cytochrome P450 enzymes and uridine 5′-diphospho-glucuronosyltransferases by vicagrel in human liver microsomes: A prediction of potential drug-drug interactions-Reference-Cited by-同舟云学术

Inhibition of cytochrome P450 enzymes and uridine 5′-diphospho-glucuronosyltransferases by vicagrel in human liver microsomes: A prediction of potential drug-drug interactions

Published:2022-01 Issue: Volume:352 Page:109775
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Liu Shuaibing^ORCID,Wang Ziteng,Chan Eric^ORCID,Zhao Yibo,Kang Jian,Zhang Xiaojian,Tian Xin

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference23 articles.

1. 2011ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American college of cardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions;Levine;Circulation,2011

2. Clinical significance of residual platelet reactivity in patients treated with platelet P2Y12 inhibitors;Thomas;Vasc. Pharmacol.,2016

3. Comparison of pharmacodynamics between low dose ticagrelor and clopidogrel after loading and maintenance doses in healthy Korean subjects;Guo;Platelets,2015

4. Cytochrome p-450 polymorphisms and response to clopidogrel;Mega;N. Engl. J. Med.,2009

5. Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel;Savi;Biochem. Pharmacol.,1992

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of the human Cytochrome P450 enzymes (P450s) responsible for metabolizing infigratinib to its pharmacologically active Metabolites, BHS697, and CQM157, and assessment of their in vitro inhibition of P450s and UDP-glucuronosyltransferases (UGTs);Biochemical Pharmacology;2024-08

2. Recent Progress on Physiologically Based Pharmacokinetic (PBPK) Model: A Review Based on Bibliometrics;Toxics;2024-06-14